BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12871951)

  • 1. Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products.
    Xu D; Kyriakis JM
    J Biol Chem; 2003 Oct; 278(41):39349-55. PubMed ID: 12871951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries.
    Lin CL; Wang FS; Kuo YR; Huang YT; Huang HC; Sun YC; Kuo YH
    Kidney Int; 2006 May; 69(9):1593-600. PubMed ID: 16572112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylglyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Inflammation via Interaction with RAGE in Mesangial Cells.
    Lee HW; Gu MJ; Lee JY; Lee S; Kim Y; Ha SK
    Mol Nutr Food Res; 2021 Jul; 65(13):e2000799. PubMed ID: 33890707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells.
    Wu D; Peng F; Zhang B; Ingram AJ; Gao B; Krepinsky JC
    Diabetologia; 2007 Sep; 50(9):2008-2018. PubMed ID: 17622510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C.
    Tuttle KR; Johnson EC; Cooney SK; Anderberg RJ; Johnson EK; Clifton GD; Meek RL
    Kidney Int; 2005 Mar; 67(3):953-68. PubMed ID: 15698434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin signalling and regulation of protein kinases in glomerular mesangial cells.
    Sorokin A; Foschi M; Dunn MJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():132S-136S. PubMed ID: 12193071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway.
    Haneda M; Koya D; Kikkawa R
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S178-81. PubMed ID: 11576950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
    Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells.
    Sheu ML; Ho FM; Chao KF; Kuo ML; Liu SH
    Mol Pharmacol; 2004 Jul; 66(1):187-96. PubMed ID: 15213311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK mediates effects of glycated albumin in mesangial cells.
    Cohen MP; Shea E; Shearman CW
    Biochem Biophys Res Commun; 2001 May; 283(3):641-3. PubMed ID: 11341772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors.
    McMahon B; Stenson C; McPhillips F; Fanning A; Brady HR; Godson C
    J Biol Chem; 2000 Sep; 275(36):27566-75. PubMed ID: 10869343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
    Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro.
    Yan L; Sun A; Xu X
    Med Sci Monit; 2019 Nov; 25():8753-8763. PubMed ID: 31745068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.